Neurocrine Biosciences Statistics

Total Valuation

BVMF:N1BI34 has a market cap or net worth of BRL 64.50 billion. The enterprise value is 59.46 billion.

Market Cap	64.50B
Enterprise Value	59.46B

Important Dates

The next confirmed earnings date is Tuesday, May 5, 2026.

Earnings Date	May 5, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-1.16%
Shares Change (QoQ)	+1.17%
Owned by Insiders (%)	1.21%
Owned by Institutions (%)	100.53%
Float	99.29M

Valuation Ratios

The trailing PE ratio is 24.47 and the forward PE ratio is 13.09.

PE Ratio	24.47
Forward PE	13.09
PS Ratio	4.09
PB Ratio	3.60
P/TBV Ratio	3.60
P/FCF Ratio	15.64
P/OCF Ratio	14.96
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.33, with an EV/FCF ratio of 14.42.

EV / Earnings	22.55
EV / Sales	4.16
EV / EBITDA	16.33
EV / EBIT	18.67
EV / FCF	14.42

Financial Position

The company has a current ratio of 3.39, with a Debt / Equity ratio of 0.14.

Current Ratio	3.39
Quick Ratio	2.92
Debt / Equity	0.14
Debt / EBITDA	0.65
Debt / FCF	0.63
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 16.38% and return on invested capital (ROIC) is 18.73%.

Return on Equity (ROE)	16.38%
Return on Assets (ROA)	9.53%
Return on Invested Capital (ROIC)	18.73%
Return on Capital Employed (ROCE)	16.37%
Weighted Average Cost of Capital (WACC)	5.94%
Revenue Per Employee	7.88M
Profits Per Employee	1.32M
Employee Count	2,000
Asset Turnover	0.69
Inventory Turnover	16.90

Taxes

In the past 12 months, BVMF:N1BI34 has paid 1.25 billion in taxes.

Income Tax	1.25B
Effective Tax Rate	32.15%

Stock Price Statistics

The stock price has increased by +5.72% in the last 52 weeks. The beta is 0.35, so BVMF:N1BI34's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	+5.72%
50-Day Moving Average	35.90
200-Day Moving Average	35.87
Relative Strength Index (RSI)	33.14
Average Volume (20 Days)	152

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.90

Income Statement

In the last 12 months, BVMF:N1BI34 had revenue of BRL 15.76 billion and earned 2.64 billion in profits. Earnings per share was 25.72.

Revenue	15.76B
Gross Profit	9.87B
Operating Income	3.51B
Pretax Income	3.89B
Net Income	2.64B
EBITDA	3.67B
EBIT	3.51B
Earnings Per Share (EPS)	25.72

Balance Sheet

The company has 8.15 billion in cash and 2.60 billion in debt, giving a net cash position of 5.56 billion.

Cash & Cash Equivalents	8.15B
Total Debt	2.60B
Net Cash	5.56B
Net Cash Per Share	n/a
Equity (Book Value)	17.92B
Book Value Per Share	179.00
Working Capital	9.80B

Cash Flow

In the last 12 months, operating cash flow was 4.31 billion and capital expenditures -187.27 million, giving a free cash flow of 4.12 billion.

Operating Cash Flow	4.31B
Capital Expenditures	-187.27M
Depreciation & Amortization	150.36M
Net Borrowing	n/a
Free Cash Flow	4.12B
FCF Per Share	n/a

Margins

Gross margin is 62.67%, with operating and profit margins of 22.25% and 16.73%.

Gross Margin	62.67%
Operating Margin	22.25%
Pretax Margin	24.66%
Profit Margin	16.73%
EBITDA Margin	23.30%
EBIT Margin	22.25%
FCF Margin	26.17%

Dividends & Yields

BVMF:N1BI34 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.16%
Shareholder Yield	1.16%
Earnings Yield	4.09%
FCF Yield	6.39%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BVMF:N1BI34 has an Altman Z-Score of 7.33 and a Piotroski F-Score of 5.

Altman Z-Score	7.33
Piotroski F-Score	5